HomeAI · summaries
Storia in 13 fonti
One in five patients achieve functional hepatitis B cure after 24 weeks of bepirovirsen
In an editorial published in the New England Journal of Medicine, University of Michigan Health hepatologist Anna S. Lok, M.D., hails newly announced results of the B-Well clinical trials as "a major step toward a functional cure for hepatitis B virus infection."
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
GSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’
The findings supporting bepirovirsen were deemed a “historic moment” by physicians and validate a drug that has “clear blockbuster potential,” according to one analyst.
- ·
apnews.com
Experimental hepatitis B drug may offer 'functional cure' for some patients
New research suggests a first-of-its-kind drug for hepatitis B may let some patients stop treatment without showing signs of the dangerous liver virus.
